Dr. Ruddy is Professor of Oncology at Mayo Clinic in Rochester, MN. Her contributions to cancer survivorship research are exceptional, resulting in prestigious national and local leadership roles in symptom and population science. She has maintained continuous federal funding for more than a decade, resulting in an outstanding publication record (with more than 30 publications per year for each of the past three years). She was recruited from Dana-Farber in 2013 to direct the Cancer Survivorship Program for the Mayo Clinic Rochester Department of Oncology, and she now co-leads the Cancer Prevention, Control, and Survivorship Program and leads the Population Sciences and Community Interventions Disease Group for the Mayo Clinic Comprehensive Cancer Center across all sites. Nationally, she is a Special Expert on QOL/Supportive Care for the National Cancer Institute Breast Cancer Steering Committee, an Associate Editor for the Journal of the National Cancer Institute, a Senior Advisor for JACC: Cardio-oncology, and a member of the American Society of Clinical Oncology (ASCO) Health Services Research and Quality Improvement track of the Education Committee for the ASCO Annual Meeting. She is also co-chair of the Symptom Intervention Committee for the Alliance for Clinical Trials in Oncology, which provides her the opportunity to work with patient advocates, Alliance staff, and other investigators to develop and shepherd cooperative group clinical trials that mitigate burdensome symptoms in patients with cancer. 

Dr. Ruddy’s research interests include:

• Patient-reported outcomes and cancer survivorship
• Prevention of premenopausal breast cancer
• Male breast cancer
• Prediction and management of side effects of cancer treatment